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Abstracts / Biol Blood Marrow Transplant 20 (2014) S91eS103 S103Findings & Interpretation: Preliminary project ﬁndings
indicate promise for the standard practice of transfusing one
unit of RBCs per low hemoglobin episode for allogeneic bone
marrow transplant and autologous bone marrow transplant
patients. After data collection is complete, formal statistics
will be completed to compare the mean number of RBC units
between the practice of routinely transfusing 1 RBC unit and
the practice of routinely transfusing 2 RBC units, as well as
comparing length of stay and costs. Early conclusions suggest
the goal of improving the safety of blood transfusions and
preserving a precious resource might be achieved with this
important practice change for two groups of oncology pa-
tients. These results will inform other practice settings to
improve their use of blood management products for
oncology patients and promote patient safety and cost-
effective practices. Use of the UHC database as a meaningful
resource for practice improvement projects and research
studies will be highlighted. Continued evaluation and
ongoing improvement of blood management practices at the
project site will be discussed with suggestions for other
settings and practices.
Discussion & Implications: This will help improve the
safety of blood transfusions. It could guide future studies
with baseline information from this transfusion practice
change. Other oncology areas could adopt a similar practice
change, educate patients and clinicians on safe transfusion
practices.122
Away with the Alcohol: The Impact on Clostridium
Difﬁcile Infection (CDI) Rate on a Complex Bone Marrow
Transplant Unit
Laura Flesch, Melissa Hayward, Kathy Demmel,
Ra’Shawn Brown, Michael Cloughessy. Cincinnati Children’s
Hospital Medical Center, Cincinnati, Ohio
Topic Signiﬁcance & Study Purpose/Background/
Rationale: This Bone Marrow Transplant Unit (BMT) is a 24
bed critical care environment that cares for a highly complex
patient population with underlying oncologic, immunologic,
marrow failure, and metabolic disorders. Hand hygiene is
stressed and alcohol gel products are located inside and
outside patient rooms. Infection Control (IC) conducts daily
surveys for patient infections and reports them to BMT staff.
During 2009, an increase in Clostridium Difﬁcile Infection
(CDI) cases was detected on the BMT unit.
Methods, Intervention, & Analysis: Due to the frequency of
CDI, isolation and environmental cleaning practices were
evaluated. Bleachwas implemented for discharge cleaning and
hand washing with soap and water on patient room exit was
reinforced with education and signage, to both staff and
caregivers. BMT staff and IC implemented initiatives to de-
clutter the unit and facilitate environmental cleaning. After
these initiatives, the number of CDI remained high. After re-
view, in September of 2010, alcohol gelswere removed from all
patient rooms and a “gel in, wash out” initiative was adopted.
Findings & Interpretation: After alcohol gel was removed
from patient rooms, the number of CDI cases has fallen and
the days between CDI have increased. In the midst of other
interventions, it appears the greatest impact for the decrease
was related to the simple intervention of removing alcohol
gel from inside patient rooms, and instituting hand washing
with soap and water before exiting a patient room. Prior to
the alcohol gel removal, the CDI rate was 1.68 infections per
1000 patient days. The intervention decreased the rate to
0.35 infections per 1000 patient days, a signiﬁcant 79% rate
reduction.Discussion & Implications: Hand washing when exiting
patient rooms enhances patient safety by removing Clos-
tridium Difﬁcile spores and other pathogens that may not be
killed by alcohol gel products.123
Human Herpes Virus-6 Viremia is associated with poor
clinical outcomes in Children following Allogeneic
Hematopoietic Cell Transplantation (AlloHCT)- Statistical
Noise or a Real problem?
Leah Violago, Evelyn Rustia, Zhezhen Jin, Monica Bhatia,
Andrew Kung. Department of Nursing, New York-Presbyterian
Morgan Stanley Children’s Hospital, NewYork, New York
Topic Signiﬁcance & Study Purpose/Background/
Rationale: Human Herpes Virus 6 (HHV-6) is an evolving
pathogen in the ﬁeld of AlloHCT. The impact of HHV-6
viremia on AlloHCT outcomes in children has not been well
described. At our center, one patient died fromHHV-6 and/or
its treatment; another asymptomatic patient had a very high
HHV-6 viral load (>1 million copies/ml) that was refractory
to treatment with Ganciclovir, Foscarnet and Cidofovir. These
two cases prompted us to create a standard operating pro-
cedure for HHV6 monitoring in an effort analyze the clinical
impact of HHV-6 viremia following AlloHCT.
Methods, Intervention, & Analysis: We monitored weekly
HHV-6 PCR starting pre-AlloHCT and up to Day +180 post-
transplant from 2008-2012 on 100 children (median age, 8
years; range 0.25-22 years; 35 F/65 M) undergoing AlloHCT
for both malignant (n¼53) and non-malignant (n¼47) dis-
eases. Conditioning regimens consisted of either myeloa-
blative (n¼43, 43%), reduced toxicity (n¼34, 34%) or reduced
intensity (n¼23, 23%) regimens with 47% of total patients
receiving alemtuzumab and 30% of total patients receiving
rabbit anti-thymocyte globulin. Donor sources included
matched family donor (n¼42, 42%), matched unrelated
donor (n¼28, 28%) and unrelated cord blood (n¼20, 20%).
Findings & Interpretation: The incidence of pre-AlloHCT
HHV-6 viremia was 3% (n¼3). Following AlloHCT, 18 patients
developed HHV-6 viremia and 10 patients had recurrence of
viremia. The incidence of peri-AlloHCT (day 0- day+14), early
(day +15-day+98) and late HHV-6 viremia (>day +98) was
5%, 14% and 9%, respectively. The average time to clear
viremia was 6 weeks (range 1-23 weeks). The median time
to platelet engraftment in patients with HHV-6 viremia
was delayed in relation to unaffected patients (p¼0.004).
Furthermore, the incidence of platelet engraftment by day
+180 was lower in patients with viremia than in unaffected
counterparts (p¼0.038). Overall, HHV-6 viremia was associ-
ated with higher transplant- related mortality [TRM] (0.003)
[Table] though we did not observe any case of encephalop-
athy or deaths directly related to the HHV-6 itself.
Discussion & Implications: With this study, we demon-
strate that HHV-6 is prevalent in children undergoing
AlloHCT and that HHV-6 viremia is associated with signiﬁ-
cant platelet engraftment delay and transplant related mor-
tality. Further clinical sequelae of HHV-6 viremia remain
difﬁcult to ascertain. Each PCR test costs $120 resulting in
approximately $250,000-300,000 of hospital cost over the
four-year study period. . Due to lack of clear understanding of
clinical consequences, we no longer routinely perform PCR
monitoring of HHV-6. To elucidate the role of HHV-6, uni-
variate and multivariate analysis will be conducted to study
various risk factors that may contribute to delayed platelet
engraftment and TRM post-AlloHCT in an effort to identify
who might beneﬁt from routine HHV-6 PCR monitoring in
the future.
